Infarma

On March 26, 1993, the Association of Representatives of Innovative Pharmaceutical Companies was registered with the Warsaw Provincial Court. A few days later, the first meeting of the General Meeting took place at the seat of SPIFF, at which the statute of the association was approved, the Management Board, Supervisory Board and Disciplinary Court were elected. On May 5, 1993, the association officially notified the Minister of Health and Social Welfare of its existence.

The Employers' Union of Innovative Pharmaceutical Companies INFARMA represents 25 leading companies in the pharmaceutical sector, conducting research and development activities and producing innovative drugs.

INFARMA is a member of the international organization associating the innovative pharmaceutical industry - the European Federation of Pharmaceutical Industry and Associations (EFPIA), as well as Employers of Poland and the Polish Chamber of Commerce.

The goal of INFARMA is to undertake initiatives positively influencing the creation of system solutions in the field of healthcare in Poland. Such solutions should enable Polish patients to use modern and most effective therapies, so that Polish treatment standards correspond to the global ones.